Contact this trialFirst, we need to learn more about you.
Cyclin-Dependent Kinase (CDK) Inhibitor
Abemaciclib for Meningioma
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is to study if the drug abemaciclib can be used to treat brain tumors by comparing it to a placebo. It is a randomized, double-blinded study, where neither the participants nor researchers know which treatment is being given.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.